Meta-analysis of placebo-controlled trials with mirtazapine using the core items of the Hamilton Depression Scale as evidence of a pure antidepressive effect in the short-term treatment of major depression

International Journal of Neuropsychopharmacology

Volumn 4, Issue 4, 2001, Pages 337-345

  Bech, Per ^a  

^a FREDERIKSBORG GENERAL HOSPITAL   (Denmark)

Author keywords

17 item HAMD scale; 6 item HAMD depression subscale; Antidepressants; Early onset of action; Effect size; Mirtazapine

Indexed keywords

AMITRIPTYLINE; BENZODIAZEPINE DERIVATIVE; CHLORAL HYDRATE; MIRTAZAPINE; PLACEBO;

ARTICLE; CLINICAL FEATURE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DOSE RESPONSE; DRUG EFFECT; DRUG MECHANISM; HUMAN; META ANALYSIS; PRIORITY JOURNAL; TREATMENT OUTCOME;

EID: 0035216177     PISSN: 14611457     EISSN: None     Source Type: Journal    
DOI: 10.1017/s1461145701002565     Document Type: Article

References (36)

1. Consensus conference on the methodology of clinical trials of antidepressants
2. Amitriptyline v. the rest: Still the leading antidepressant after 40 years of randomized controlled trials
3. The Hamilton Depression Scale. Evaluation of objectivity using logistic models
4. A meta-analysis of randomized controlled trials of fluoxetine versus placebo and tricyclic antidepressants in the short-term treatment of major depression
5. A double-blind comparison of Org 3770, amitriptyline and placebo in major depression
6. Medical statistics: Meta-analysis
7. A double-blind, placebo-controlled study of Org 3770 in depressed outpatients
8. Morning fluoxetine plus evening mianserin versus morning fluoxetine plus evening placebo in the acute treatment of major depression
9. Clomipramine dose-effect study in patients with depression: Clinical end points and pharmacokinetics
10. A meta-analysis of eight randomized, double-blind controlled clinical trials of mirtazapine for the treatment of patients with major depression and symptoms of anxiety
11. A meta-analysis of fluoxetine outcome in the treatment of depression
12. Org 37770 (mirtazapine) versus trazodone: A placebo-controlled trial in depressed elderly patients
13. Development of a rating scale for primary depressive illness
14. An examination of the sensitivity of the six-item Hamilton Rating Scale for Depression in a sample of patients suffering from major depressive disorder
15. Comparison of Org 3770 and amitriptyline in depressed outpatients
16. Clinical efficacy of mirtazapine: Review of meta-analyses on pooled data
17. Antidepressant efficacy in relation to items analysis and severity of depression: A placebo-controlled trial of fluvoxamine versus imipramine
18. The timing, specificity and clinical prediction of tricyclic drug effects in depression
19. The treatment of depressive states with G 22355 (imipramine hydrochloride)
20. The magical number of seven, plus or minus two
21. Sensitivity of the six-item Hamilton Depression Rating Scale
22. Why do we need systematic overviews of randomized trials?
23. Overcoming the limitations of current meta-analysis of randomized controlled trials
24. Methodology of measuring the efficacy of antidepressants
25. An overview of statistical issues and methods of meta-analysis
26. Meta-analysis: Unresolved issues and future developments
27. Mirtazapine vs amitriptyline vs placebo in the treatment of major depressive disorder
28. Meta-analysis of randomized, double blind, placebo controlled, efficacy and safety studies of mirtazapine versus amitriptyline in major depression
29. Publication bias: Evidence of delayed publication in a cohort study of clinical research projects
30. Anxiolytics as antidepressants
31. Double-blind study of mirtazapine and placebo in hospitalized patients with major depression